Just when we seem to have a grasp on one weight loss drug, another enters the chat
We prioritize realistic, sustainable outcomes
Durham Peptides offers bulk pricing on request contact [email protected] for a bulk quote
Current trial protocols use once-daily dosing, but the improved bioavailability could theoretically support less frequent administration in the future
Wei H, Bu R, Yang Q, Jia J, Li T, Wang Q, Chen Y: Exendin-4 Protects against Hyperglycemia-Induced Cardiomyocyte Pyroptosis via the AMPK-TXNIP Pathway
It is classified as a multi-receptor peptide agonist because it has been studied for activity across three related receptor systems: the glucose-dependent insulinotropic polypeptide receptor, the glucagon-like peptide-1 receptor, and the glucagon receptor